Loading...
Loading...
PLSE| Name | Value |
|---|---|
| Revenues | 1.7M |
| Cost of Revenue | 0.3M |
| Gross Profit | 1.4M |
| Operating Expense | 12.2M |
| Operating I/L | -12.5M |
| Other Income/Expense | 0.6M |
| Interest Income | 0.6M |
| Pretax | -11.9M |
| Income Tax Expense | 0.1M |
| Net Income/Loss | -11.9M |
Pulse Biosciences, Inc. operates as a bioelectric medicine company, offering the CellFX System. This platform delivers nano second duration pulses of electrical energy to clear targeted cells while sparing adjacent non-cellular tissue, using Nano-Pulse Stimulation technology. The system is tunable, software-enabled, and console-based, and is used to treat various medical conditions. The company generates revenue by selling the CellFX System and related services.
